Home Healthcare Biotechnology Carrier Screening Market

Carrier Screening Market Size, Share & Trends Analysis Report By Type (Expanded Carrier Screening, Targeted Disease Carrier Screening), By Technology (DNA Sequencing, Polymerase Chain Reaction, DNA Microarrays, Others), By Medical Condition (Pulmonary, Hematology, Neurology, Rare Disease, Others), By End Use (Hospitals, Laboratories, Physician Offices & Clinics, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: December 01, 2025 | Author: Debashree B | Format: | Report Code: SR7445DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Carrier Screening Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Expanded Carrier Screening
    2. Targeted Disease Carrier Screening
  2. Carrier Screening Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. DNA Sequencing
    2. Polymerase Chain Reaction
    3. DNA Microarrays
    4. Others
  3. Carrier Screening Market, By Medical Condition 2022-2034 (USD MILLION/ Units)
    1. Pulmonary
    2. Hematology
    3. Neurology
    4. Rare Disease
    5. Others
  4. Carrier Screening Market, By End Use 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Laboratories
    3. Physician Offices & Clinics
    4. Others
  5. Regional Carrier Screening Market
    1. North America
      1. North America Carrier Screening Market By Type 2022-2034 (USD MILLION/ Units)
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
      2. North America Carrier Screening Market By Technology 2022-2034 (USD MILLION/ Units)
        1. DNA Sequencing
        2. Polymerase Chain Reaction
        3. DNA Microarrays
        4. Others
      3. North America Carrier Screening Market By Medical Condition 2022-2034 (USD MILLION/ Units)
        1. Pulmonary
        2. Hematology
        3. Neurology
        4. Rare Disease
        5. Others
      4. North America Carrier Screening Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Laboratories
        3. Physician Offices & Clinics
        4. Others
      5. U.S.
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
      6. Canada
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
    2. Europe
      1. Europe Carrier Screening Market By Type 2022-2034 (USD MILLION/ Units)
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
      2. Europe Carrier Screening Market By Technology 2022-2034 (USD MILLION/ Units)
        1. DNA Sequencing
        2. Polymerase Chain Reaction
        3. DNA Microarrays
        4. Others
      3. Europe Carrier Screening Market By Medical Condition 2022-2034 (USD MILLION/ Units)
        1. Pulmonary
        2. Hematology
        3. Neurology
        4. Rare Disease
        5. Others
      4. Europe Carrier Screening Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Laboratories
        3. Physician Offices & Clinics
        4. Others
      5. U.K.
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
      6. Germany
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
      7. France
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
      8. Spain
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
      9. Italy
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
      10. Russia
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
      11. Nordic
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
      12. Benelux
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
      13. Rest of Europe
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
    3. APAC
      1. APAC Carrier Screening Market By Type 2022-2034 (USD MILLION/ Units)
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
      2. APAC Carrier Screening Market By Technology 2022-2034 (USD MILLION/ Units)
        1. DNA Sequencing
        2. Polymerase Chain Reaction
        3. DNA Microarrays
        4. Others
      3. APAC Carrier Screening Market By Medical Condition 2022-2034 (USD MILLION/ Units)
        1. Pulmonary
        2. Hematology
        3. Neurology
        4. Rare Disease
        5. Others
      4. APAC Carrier Screening Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Laboratories
        3. Physician Offices & Clinics
        4. Others
      5. China
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
      6. Korea
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
      7. Japan
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
      8. India
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
      9. Australia
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
      10. Taiwan
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
      11. South East Asia
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
      12. Rest of Asia-Pacific
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
    4. Middle East and Africa
      1. Middle East and Africa Carrier Screening Market By Type 2022-2034 (USD MILLION/ Units)
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
      2. Middle East and Africa Carrier Screening Market By Technology 2022-2034 (USD MILLION/ Units)
        1. DNA Sequencing
        2. Polymerase Chain Reaction
        3. DNA Microarrays
        4. Others
      3. Middle East and Africa Carrier Screening Market By Medical Condition 2022-2034 (USD MILLION/ Units)
        1. Pulmonary
        2. Hematology
        3. Neurology
        4. Rare Disease
        5. Others
      4. Middle East and Africa Carrier Screening Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Laboratories
        3. Physician Offices & Clinics
        4. Others
      5. UAE
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
      6. Turkey
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
      7. Saudi Arabia
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
      8. South Africa
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
      9. Egypt
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
      10. Nigeria
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
      11. Rest of MEA
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
    5. LATAM
      1. LATAM Carrier Screening Market By Type 2022-2034 (USD MILLION/ Units)
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
      2. LATAM Carrier Screening Market By Technology 2022-2034 (USD MILLION/ Units)
        1. DNA Sequencing
        2. Polymerase Chain Reaction
        3. DNA Microarrays
        4. Others
      3. LATAM Carrier Screening Market By Medical Condition 2022-2034 (USD MILLION/ Units)
        1. Pulmonary
        2. Hematology
        3. Neurology
        4. Rare Disease
        5. Others
      4. LATAM Carrier Screening Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Laboratories
        3. Physician Offices & Clinics
        4. Others
      5. Brazil
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
      6. Mexico
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
      7. Argentina
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
      8. Chile
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
      9. Colombia
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
      10. Rest of LATAM
        1. Expanded Carrier Screening
        2. Targeted Disease Carrier Screening
        3. DNA Sequencing
        4. Polymerase Chain Reaction
        5. DNA Microarrays
        6. Others
        7. Pulmonary
        8. Hematology
        9. Neurology
        10. Rare Disease
        11. Others
        12. Hospitals
        13. Laboratories
        14. Physician Offices & Clinics
        15. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.